These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18030515)

  • 61. Achieving sustained minimal disease activity with methotrexate in early interleukin 23-driven early psoriatic arthritis.
    den Braanker H; Wervers K; Mus AMC; Bangoer PS; Davelaar N; Luime J; Tchetverikov I; Hazes JMW; Vis M; Lubberts E; Kok MR
    RMD Open; 2020 Jul; 6(2):. PubMed ID: 32669451
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Factors influencing length of time taking methotrexate in rheumatoid arthritis.
    Ortendahl M; Schettler JD; Fries JF
    J Rheumatol; 2000 May; 27(5):1139-47. PubMed ID: 10813279
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis.
    Dupuis LL; Koren G; Shore A; Silverman ED; Laxer RM
    J Rheumatol; 1990 Nov; 17(11):1469-73. PubMed ID: 2273487
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study.
    Chimenti MS; Ortolan A; Lorenzin M; Triggianese P; Talamonti M; Costa L; Caso F; Favero M; Teoli M; Galluzzo M; Scarpa R; Punzi L; Perricone R; Ramonda R
    Clin Rheumatol; 2018 Feb; 37(2):397-405. PubMed ID: 29302829
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of NSAIDs in psoriatic arthritis: evidence from a controlled study with nimesulide.
    Sarzi-Puttini P; Santandrea S; Boccassini L; Panni B; Caruso I
    Clin Exp Rheumatol; 2001; 19(1 Suppl 22):S17-20. PubMed ID: 11296544
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The association of clinical parameters and ultrasound verified inflammation with patients' and physicians' global assessments in psoriatic arthritis.
    Lackner A; Duftner C; Ficjan A; Gretler J; Hermann J; Husic R; Graninger WB; Dejaco C
    Semin Arthritis Rheum; 2016 Oct; 46(2):183-189. PubMed ID: 27373500
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
    Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE; Gülfe A; Saxne T; Geborek P
    Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Efficacy of Shenshi Qianghuo Dihuang Decoction in rheumatoid arthritis: a randomized controlled trial].
    Chen ZW; Sun J; Li YM; Chen YQ
    Zhong Xi Yi Jie He Xue Bao; 2010 Jan; 8(1):35-9. PubMed ID: 20082756
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
    Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
    Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Achieving remission in psoriatic arthritis by early initiation of TNF inhibition: a double-blind, randomised, placebo-controlled trial of golimumab plus methotrexate versus placebo plus methotrexate.
    van Mens LJJ; de Jong HM; Fluri I; Nurmohamed MT; van de Sande MGH; Kok M; van Kuijk AWR; Baeten D
    Ann Rheum Dis; 2019 May; 78(5):610-616. PubMed ID: 30808625
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group.
    Stein CM; Pincus T; Yocum D; Tugwell P; Wells G; Gluck O; Kraag G; Torley H; Tesser J; McKendry R; Brooks RH
    Arthritis Rheum; 1997 Oct; 40(10):1843-51. PubMed ID: 9336420
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes.
    De Marco G; Helliwell P; McGonagle D; Emery P; Coates LC; Hensor EMA; Marzo-Ortega H
    BMC Musculoskelet Disord; 2017 Jul; 18(1):303. PubMed ID: 28720139
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combination.
    Strand V; Mease PJ; Maksabedian Hernandez EJ; Stolshek BS; Liu LXH; Collier DH; Kricorian G; Merola JF
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33452180
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate.
    Kaeley GS; MacCarter DK; Pangan AL; Wang X; Kalabic J; Ranganath VK
    J Rheumatol; 2018 Dec; 45(12):1628-1635. PubMed ID: 30173153
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Methotrexate for ankylosing spondylitis.
    Chen J; Liu C; Lin J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004524. PubMed ID: 17054209
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis.
    Behrens F; Koehm M; Schwaneck EC; Schmalzing M; Wittig BM; Gnann H; Greger G; Tony HP; Burkhardt H
    Scand J Rheumatol; 2019 Sep; 48(5):375-382. PubMed ID: 31311386
    [No Abstract]   [Full Text] [Related]  

  • 78. E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy.
    Visvanathan S; Wagner C; Rojas J; Kay J; Dasgupta B; Matteson EL; Mack M; Baker DG; Rahman MU
    J Rheumatol; 2009 Jul; 36(7):1371-9. PubMed ID: 19487269
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effectiveness of early adalimumab therapy in psoriatic arthritis patients from Reuma.pt - EARLY PsA.
    Santos H; Eusébio M; Borges J; Gonçalves D; Ávila-Ribeiro P; Faria DS; Lopes C; Rovisco J; Águeda A; Nero P; Valente P; Cravo AR; Santos MJ
    Acta Reumatol Port; 2017; 42(4):287-299. PubMed ID: 29342473
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.
    Gerloni V; Pontikaki I; Gattinara M; Desiati F; Lupi E; Lurati A; Salmaso A; Fantini F
    Arthritis Rheum; 2005 Feb; 52(2):548-53. PubMed ID: 15693004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.